Silicon Labs Reports Third Quarter 2025 Results
Wireless IoT leader delivers sequential and year-over-year growth in sales and profitability
AUSTIN, Texas, Nov. 4, 2025 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, reported financial results for the third quarter, which ended October 4, 2025.
"The Silicon Labs team delivered sequential and year-over-year growth in sales and profitability driven by strong execution across our business," said Matt Johnson, President and Chief Executive Officer at Silicon Labs. "Looking ahead, we remain focused on supporting new customer ramps, maintaining operational discipline, and driving continued earnings growth."
Third Quarter Financial Highlights
Results on a GAAP basis:
Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:
Business Highlights
Business Outlook
The company expects fourth-quarter revenue to be between $200 to $215 million. The company also estimates the following results:
On a GAAP basis:
On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables:
Earnings Webcast and Conference Call
Silicon Labs will host an earnings conference call to discuss the quarterly results and answer questions at 7:30 am CDT today. An audio webcast will be available on Silicon Labs' website ( www.silabs.com) under Investor Relations. In addition, the company will post an audio recording of the event at investor.silabs.com and make a replay available through December 4, 2025.
About Silicon Labs
Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in the smart home, industrial IoT, and smart cities markets. Learn more at silabs.com.
Forward-Looking Statements
This press release contains forward-looking statements based on Silicon Labs' current expectations. The words "believe", "estimate", "expect", "intend", "anticipate", "plan", "project", "will", and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: fluctuating changes in global trade policies, including the imposition of tariffs, duties, trade sanctions, or other barriers to international commerce; the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs' business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs' distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of public health crises on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs' products and its networks; risks associated with any material weakness in our internal controls over financial reporting; risks relating to compliance with laws and regulations; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.
Note to editors: Silicon Laboratories, Silicon Labs, the "S" symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
Silicon Laboratories Inc.
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
Three Months Ended
Nine Months Ended
October 4,
2025
September 28,
2024
October 4,
2025
September 28,
2024
Revenues
$ 205,999
$ 166,395
$ 576,558
$ 418,137
Cost of revenues
86,980
76,082
251,653
196,172
Gross profit
119,019
90,313
324,905
221,965
Operating expenses:
Research and development
87,685
83,228
263,725
249,787
Selling, general and administrative
43,676
36,793
128,469
109,041
Operating expenses
131,361
120,021
392,194
358,828
Operating loss
(12,342)
(29,708)
(67,289)
(136,863)
Other income (expense):
Interest income and other, net
3,046
3,487
10,672
9,009
Interest expense
(226)
(278)
(761)
(1,050)
Loss before income taxes
(9,522)
(26,499)
(57,378)
(128,904)
Provision for income taxes
414
2,005
4,845
38,283
Net loss
$ (9,936)
$ (28,504)
$ (62,223)
$ (167,187)
Loss per share:
Basic
$ (0.30)
$ (0.88)
$ (1.91)
$ (5.21)
Diluted
$ (0.30)
$ (0.88)
$ (1.91)
$ (5.21)
Weighted-average common shares outstanding:
Basic
32,835
32,309
32,656
32,114
Diluted
32,835
32,309
32,656
32,114
Non-GAAP Financial Measurements
In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.
The non-GAAP financial measurements do not replace the presentation of Silicon Labs' GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs' financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
Three Months Ended
October 4, 2025
Non-GAAP Income Statement Items
GAAP
Measure
GAAP
Percent of
Revenue
Stock
Compensation
Expense
Intangible
Asset
Amortization
Other Costs
Non-
GAAP
Measure
Non-GAAP
Percent of
Revenue
Revenues
$ 205,999
Gross profit
119,019
57.8 %
$ 474
$ —
$ —
$ 119,493
58.0 %
Research and development
87,685
42.6 %
12,149
2,295
530
72,711
35.3 %
Selling, general and administrative
43,676
21.2 %
7,417
—
—
36,259
17.6 %
Operating expenses
131,361
63.8 %
19,566
2,295
530
108,970
52.9 %
Operating income (loss)
(12,342)
(6.0 %)
20,040
2,295
530
10,523
5.1 %
Three Months Ended
October 4, 2025
Non-GAAP Earnings (Loss) Per Share
GAAP
Measure
Stock
Compensation
Expense*
Intangible
Asset
Amortization*
Other
Costs*
Income
Tax
Adjustments
Non-
GAAP
Measure
Net income (loss)
$ (9,936)
$ 20,040
$ 2,295
$ 530
$ (2,255)
$ 10,674
Shares Excluded Due to Net Loss
Diluted shares outstanding
32,835
217
33,052
Diluted earnings (loss) per share
$ (0.30)
$ 0.32
*
Represents pre-tax amounts
Unaudited Forward-Looking Statements Regarding Business Outlook
(In millions, except per share data)
Three Months Ended
January 3, 2026
Business Outlook
GAAP
Measure
Non-GAAP
Adjustments**
Non-GAAP
Measure
Gross margin
62% to 64%
— %
62% to 64%
Operating expenses
$134 to $136
$(24)
$110 to $112
Diluted earnings (loss) per share
$(0.22) to $0.08
$0.62
$0.40 to $0.70
**
Non-GAAP adjustments include the following estimates: stock compensation expense of $20.9 million, intangible asset
amortization of $2.3 million, other costs of $1.0 million, and the application of a long-term non-GAAP tax rate of 20%.
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
October 4,
2025
December 28,
2024
Assets
Current assets:
Cash and cash equivalents
$ 341,403
$ 281,607
Short-term investments
97,622
100,554
Accounts receivable, net
67,308
54,479
Inventories
82,190
105,639
Prepaid expenses and other current assets
64,036
59,754
Total current assets
652,559
602,033
Property and equipment, net
128,323
132,136
Goodwill
376,389
376,389
Other intangible assets, net
25,425
36,499
Other assets, net
70,371
75,617
Total assets
$ 1,253,067
$ 1,222,674
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
$ 55,647
$ 42,448
Deferred revenue and returns liability
8,447
3,073
Other current liabilities
81,216
52,362
Total current liabilities
145,310
97,883
Other non-current liabilities
37,044
44,770
Total liabilities
182,354
142,653
Commitments and contingencies
Stockholders' equity:
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued
—
—
Common stock – $0.0001 par value; 250,000 shares authorized; 32,853 and 32,458
shares issued and outstanding at October 4, 2025 and December 28, 2024,
respectively
3
3
Additional paid-in capital
130,979
78,227
Retained earnings
939,498
1,001,721
Accumulated other comprehensive income
233
70
Total stockholders' equity
1,070,713
1,080,021
Total liabilities and stockholders' equity
$ 1,253,067
$ 1,222,674
Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Nine Months Ended
October 4,
2025
September 28,
2024
Operating Activities
Net loss
$ (62,223)
$ (167,187)
Adjustments to reconcile net loss to net cash provided by (used in) operating
activities:
Depreciation of property and equipment
18,769
19,302
Amortization of other intangible assets
11,074
17,596
Stock-based compensation expense
59,645
45,358
Deferred income taxes
2,026
29,100
Changes in operating assets and liabilities:
Accounts receivable
(12,829)
(19,585)
Inventories
23,316
54,724
Prepaid expenses and other assets
9,080
23,091
Accounts payable
11,141
(13,849)
Other current liabilities and income taxes
29,901
(5,004)
Deferred revenue and returns liability
5,374
6,361
Other non-current liabilities
(7,916)
(13,946)
Net cash provided by (used in) operating activities
87,358
(24,039)
Investing Activities
Purchases of marketable securities
(34,790)
(28,363)
Sales of marketable securities
15,332
44,057
Maturities of marketable securities
22,598
131,008
Purchases of property and equipment
(19,942)
(7,785)
Purchase of other investment
(4,000)
—
Proceeds from sale of equity investment
—
12,382
Net cash provided by (used in) investing activities
(20,802)
151,299
Financing Activities
Payments on debt
—
(45,000)
Payment of taxes withheld for vested stock awards
(14,907)
(16,078)
Proceeds from the issuance of common stock
8,147
9,396
Net cash used in financing activities
(6,760)
(51,682)
Increase in cash and cash equivalents
59,796
75,578
Cash and cash equivalents at beginning of period
281,607
227,504
Cash and cash equivalents at end of period
$ 341,403
$ 303,082
SOURCE Silicon Labs